Medical Oncology

Bone diesease in multiple myeloma
pp. 431-441(11)
Authors: Hjertner, Øyvind; Standal, Therese; Børset, Magne; Sundan, Anders; Waage, Anders

Risk factors, classification, and staging of renal cell cancer
pp. 443-454(12)
Author: Laber, Damian

Diffuse calcification of metastases after intensive multiagent chemotherapy in widespread osteosarcoma leading to death in a 18-year-old male: Report of a case and literature review
pp. 455-462(8)
Authors: Gassiamis, Argyris; Tsakonas, George; Soukouli, Georgia; Mylonakis, Nicolas; Karabelis, Athanasios; Kosmas, Christos

Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck
pp. 463-470(8)
Authors: Kandiloros, D.; Eleftheriadou, A.; Chalastras, T.; Kyriou, L.; Yiotakis, I.; Ferekidis, E.

Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma: A single institution's experience
pp. 471-477(7)
Authors: Tas, Faruk; Kurul, Sidika; Camlica, Hakan; Topuz, Erkan

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer
pp. 479-488(10)
Authors: Fountzilas, George; Pectasides, Dimitrios; Christodoulou, Christos; Timotheadou, Eleni; Economopoulos, Theofanis; Papakostas, Pavlos; Papadimitriou, Christos; Gogas, Helen; Efstratiou, Ioannis; Skarlos, Dimosthenis

Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
pp. 489-498(10)
Authors: Park, So-Yeon; Hong, Yun-Chul; Kim, Jin-Hee; Kwak, Seung-Min; Cho, Jae-Hwa; Lee, Hong-Lyeol; Ryu, Jeong-Seon

Mid-course thoracic radiotherapy with cisplatin-etoposide chemotherapy in limited-stage small-cell lung cancer
pp. 499-505(7)
Authors: Akyurek, Serap; Onal, Cem; Cagar, Aysun; Hicsonmez, Ayse; Andrieu, Meltem; Kurtman, Cengiz

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
pp. 507-513(7)
Authors: Kalmadi, Sujith; McNeill, Giles; Davis, Mellar; Peereboom, David; Adelstein, David; Mekhail, Tarek

Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer
pp. 515-519(5)
Authors: Shonka, Nicole; Anderson, James; Panwalkar, Amit; Reed, Elizabeth; Steen, Preston; Ganti, Apar

Adjuvant chemotherapy in elderly patients (≥75 yr) completely resected for colon cancer stage III compared to younger patients: Toxicity and prognosis
pp. 521-531(11)
Authors: Jensen, Søren; Vilmar, Adam; Sørensen, Jens

Predictive value of prognostic indices in patients with follicular lymphomas
pp. 533-542(10)
Authors: Radojkovic, M.; Ristic, S.; Colovic, M.; Mihaljevic, B.; Cemerikic-Martinovic, V.

Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma
pp. 543-548(6)
Authors: Karagol, Hakan; Saip, Pinar; Uygun, Kazim; Kucucuk, Seden; Aydiner, Adnan; Topuz, Erkan

Prevention of chemotherapy-induced neutropenia by special honey intake
pp. 549-552(4)
Authors: Zidan, Jamal; Shetver, Lika; Gershuny, Anthony; Abzah, Amira; Tamam, Sigalit; Stein, Moshe; Friedman, Eitan

Small molecule antagonists of the TGF-β1/TGF-β receptor binding interaction
pp. 553-562(10)
Authors: Burmester, James; Salzman, Sherry; Zhang, Kai; Dart, Richard